CSIMarket Company Name, Ticker, Industry, else..
 
Myomo Inc   (NYSEAMER: MYO)
Other Ticker:  
 
 
Price: $5.1900 $0.12 2.367%
Day's High: $5.2799 Week Perf: 24.46 %
Day's Low: $ 5.06 30 Day Perf: -17.49 %
Volume (M): 388 52 Wk High: $ 7.17
Volume (M$): $ 2,014 52 Wk Avg: $4.42
Open: $5.14 52 Wk Low: $2.51



 Market Capitalization (Millions $) 201
 Shares Outstanding (Millions) 39
 Employees 37
 Revenues (TTM) (Millions $) 32
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) 18
 Capital Exp. (TTM) (Millions $) 1

Myomo Inc
Myomo Inc is a medical robotics company based in the United States. The company specializes in developing and commercializing wearable robotic devices designed to help individuals regain the use of their paralyzed or weakened limbs. Myomo's robotic devices, known as MyoPro, are designed to provide assistance to people with neuromuscular conditions such as stroke, spinal cord injury, and multiple sclerosis.

The MyoPro devices work by sensing the user's own muscle signals through non-invasive sensors and amplifying those signals to generate movement in the affected limb. This allows individuals with limited mobility to regain control over their paralyzed or weakened limb and perform daily tasks with greater independence.

Myomo Inc has received FDA approval for its MyoPro devices and has successfully marketed them to rehabilitation hospitals and clinics, as well as directly to individuals. The company aims to improve the quality of life for people with neuromuscular conditions by providing them with innovative and effective solutions to regain mobility and independence.


   Company Address: 45 Blue Sky Dr Burlington 1803 MA
   Company Phone Number: 996-9058   Stock Exchange / Ticker: NYSEAMER MYO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ELMD   -0.32%    
EMBC   -5.8%    
MDT   -0.78%    
PODD        7.75% 
PROF        3.12% 
TNDM        5.56% 
• View Complete Report
   



Myomo Inc

Myomo Inc Shines with Impressive 13.12% Revenue Growth in Q3 2023

The stock market is a constantly evolving and dynamic world that captures the attention of investors around the globe. With its ups and downs, it offers both opportunities and risks. Today, we focus on Myomo Inc, a leading Medical Equipment & Supplies company, and delve into their recent financial performance.
In the report for the third quarter of 2023, Myomo Inc showcased a commendable growth in revenue, with a substantial increase of 13.12% compared to the same period last year, reaching an impressive $4.49 million. This growth puts Myomo Inc ahead of its industry peers, who only managed a 4.03% increase during the same timeframe. It is encouraging to see a company outperforming others in its sector, reaffirming Myomo Inc's dominance in the market.
Myomo Inc

Myomo Inc Surprises Investors with Remarkable Revenue Growth and Reduced Losses in Q2 2023

The stock market has been abuzz with positive news, especially for Myomo Inc, a company in the Medical Equipment & Supplies sector. The second quarter of 2023 has brought excellent results for Myomo, as it managed to decrease its loss per share significantly compared to the previous year. This improvement is commendable, with the loss per share reducing from $-0.42 to a mere $-0.04. Additionally, the earnings per share (EPS) have also shown progress, increasing from $-0.11 per share from the preceding reporting season.
Myomo Inc has truly impressed investors with its revenue growth. In the similar reporting season a year ago, the revenue stood at $3.68 million, but this year it has skyrocketed by 43.602%, reaching an impressive $5.28 million. Even more remarkable, the revenue surged by 53.22% from the preceding quarter, jumping from $3.45 million. This outstanding growth in the company's top-line aligns favorably with its peers in the Medical Equipment & Supplies sector, where an overall 4.51% revenue advance was observed during the same period.






Myomo Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com